<!DOCTYPE html>

<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Adverse Drug Effects - Essentials of Medical Pharmacology</title>

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">

<link rel="stylesheet" href="../styles/main.css">

<script>
MathJax = {
    tex: {
        inlineMath: [['$', '$'], ['\\(', '\\)']],
        displayMath: [['$$', '$$'], ['\\[', '\\]']],
        processEscapes: true,
        processEnvironments: true
    },
    svg: { fontCache: 'global' },
    options: {
        skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
    }
};
</script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
<a href="#main-content" class="skip-link">Skip to main content</a>

<button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
    <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
    <span class="theme-toggle-icon dark-icon">üåô</span>
</button>

<div class="reading-progress-container">
    <div class="reading-progress-bar" id="reading-progress"></div>
</div>

<!-- Floating TOC -->
<nav class="floating-toc" id="floating-toc">
    <div class="floating-toc-header">
        <span>üìë</span> Table of Contents
    </div>
    <ul class="floating-toc-list">
        <li><a href="#introduction">Definitions & Classification</a></li>
        <li><a href="#pharmacovigilance">Pharmacovigilance</a></li>
        <li><a href="#categories">Categories of Adverse Effects</a></li>
        <li><a href="#toxic-effects">Toxic Effects & Poisoning</a></li>
        <li><a href="#drug-allergy">Drug Allergy</a></li>
        <li><a href="#dependence">Dependence & Addiction</a></li>
        <li><a href="#teratogenicity">Teratogenicity</a></li>
        <li><a href="#problem-study">Problem Directed Study</a></li>
    </ul>
</nav>

<div class="page-wrapper">
    <div class="container">
        <article class="document-article">
            <header class="document-header">
                <div class="header-badge">
                    <span>‚ö†Ô∏è</span>
                    <span>Topic 06</span>
                </div>
                <h1 class="document-title">Adverse Drug Effects</h1>
                <div class="title-meta">
                    <div class="meta-item">
                        <span>üìö</span>
                        <span>General Pharmacological Principles</span>
                    </div>
                    <div class="meta-item">
                        <span>‚è±Ô∏è</span>
                        <span>30 min read</span>
                    </div>
                </div>
            </header>

            <main id="main-content" class="content-wrapper">
                <!-- Section 1: Introduction -->
                <section class="content-section" id="introduction">
                    <div class="section-header">
                        <div class="section-number">01</div>
                        <h2 class="section-title">
                            <span class="title-icon">üìñ</span>
                            Definitions & Classification
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>All drugs are capable of producing adverse effects, and whenever a drug is given a risk is taken. The magnitude of risk has to be considered along with the magnitude of expected therapeutic benefit (Risk-Benefit Ratio).</p>
                        
                        <div class="callout callout--info">
                            <div class="callout-header">
                                <span class="callout-icon">‚ÑπÔ∏è</span>
                                <h4 class="callout-title">Key Definitions</h4>
                            </div>
                            <div class="callout-content">
                                <ul class="enhanced-list">
                                    <li class="list-item"><strong>Adverse Drug Reaction (ADR):</strong> Any noxious change which is suspected to be due to a drug, occurs at doses normally used in man, requires treatment or decrease in dose or indicates caution in the future use of the same drug.</li>
                                    <li class="list-item"><strong>Adverse Drug Event (ADE):</strong> Any untoward medical occurrence that may present during treatment with a medicine, but which does not necessarily have a causal relationship with the treatment.</li>
                                </ul>
                            </div>
                        </div>

                        <h3>Classification</h3>
                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Predictable (Type A)</th>
                                        <th>Unpredictable (Type B)</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Based on pharmacological properties.</td>
                                        <td>Based on peculiarities of patient (genetics, immunology).</td>
                                    </tr>
                                    <tr>
                                        <td>Augmented, qualitatively normal response.</td>
                                        <td>Bizarre, qualitatively abnormal response.</td>
                                    </tr>
                                    <tr>
                                        <td>More common, dose related.</td>
                                        <td>Less common, non-dose related.</td>
                                    </tr>
                                    <tr>
                                        <td>Includes side effects, toxic effects.</td>
                                        <td>Includes allergy, idiosyncrasy.</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Severity Grading</h3>
                        <ul>
                            <li><strong>Minor:</strong> No therapy, antidote or prolongation of hospitalization required.</li>
                            <li><strong>Moderate:</strong> Requires change in drug therapy, specific treatment or prolongs hospital stay by at least one day.</li>
                            <li><strong>Severe:</strong> Potentially life-threatening, causes permanent damage or requires intensive medical treatment.</li>
                            <li><strong>Lethal:</strong> Directly or indirectly contributes to death of the patient.</li>
                        </ul>
                    </div>
                </section>

                <!-- Section 2: Pharmacovigilance -->
                <section class="content-section" id="pharmacovigilance">
                    <div class="section-header">
                        <div class="section-number">02</div>
                        <h2 class="section-title">
                            <span class="title-icon">üëÅÔ∏è</span>
                            Pharmacovigilance
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug related problems.</p>
                        
                        <h3>Causality Assessment</h3>
                        <p>When an adverse event occurs, causality is assessed based on:</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="list-marker"></span> <strong>Temporal relationship:</strong> Time sequence.</li>
                            <li class="list-item"><span class="list-marker"></span> <strong>Previous knowledge:</strong> Known reaction to the drug.</li>
                            <li class="list-item"><span class="list-marker"></span> <strong>Dechallenge:</strong> Event subsides on stopping drug.</li>
                            <li class="list-item"><span class="list-marker"></span> <strong>Rechallenge:</strong> Event reappears on re-administration (often not done).</li>
                        </ul>
                        
                        <p><strong>Grading:</strong> Definite, Probable, Possible, Doubtful.</p>

                        <h3>Prevention of Adverse Effects</h3>
                        <ol class="enhanced-list">
                            <li class="list-item">Avoid inappropriate use.</li>
                            <li class="list-item">Use appropriate dose, route and frequency.</li>
                            <li class="list-item">Elicit history of drug reactions/allergies.</li>
                            <li class="list-item">Rule out drug interactions.</li>
                            <li class="list-item">Adopt correct administration technique.</li>
                            <li class="list-item">Carry out laboratory monitoring.</li>
                        </ol>
                    </div>
                </section>

                <!-- Section 3: Categories -->
                <section class="content-section" id="categories">
                    <div class="section-header">
                        <div class="section-number">03</div>
                        <h2 class="section-title">
                            <span class="title-icon">üóÇÔ∏è</span>
                            Categories of Adverse Effects
                        </h2>
                    </div>

                    <div class="content-card">
                        <div class="grid grid-2">
                            <div class="grid-item">
                                <h4>1. Side Effects</h4>
                                <p>Unwanted but often unavoidable pharmacodynamic effects that occur at therapeutic doses. Can be predicted.</p>
                                <p><em>Examples:</em> Dry mouth with atropine, sedation with antihistamines.</p>
                            </div>
                            <div class="grid-item">
                                <h4>2. Secondary Effects</h4>
                                <p>Indirect consequences of a primary action of the drug.</p>
                                <p><em>Examples:</em> Superinfections with tetracyclines, activation of latent TB with corticosteroids.</p>
                            </div>
                            <div class="grid-item">
                                <h4>3. Intolerance</h4>
                                <p>Appearance of characteristic toxic effects at therapeutic doses due to low threshold of the individual.</p>
                                <p><em>Example:</em> Vomiting with one tablet of chloroquine.</p>
                            </div>
                            <div class="grid-item">
                                <h4>4. Idiosyncrasy</h4>
                                <p>Genetically determined abnormal reactivity. The drug interacts with some unique feature of the individual.</p>
                                <p><em>Examples:</em> Excitement with barbiturates, aplastic anaemia with chloramphenicol.</p>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 4: Toxic Effects -->
                <section class="content-section" id="toxic-effects">
                    <div class="section-header">
                        <div class="section-number">04</div>
                        <h2 class="section-title">
                            <span class="title-icon">‚ò†Ô∏è</span>
                            Toxic Effects & Poisoning
                        </h2>
                    </div>

                    <div class="content-card">
                        <p><strong>Toxic effects</strong> are the result of excessive pharmacological action of the drug due to overdosage or prolonged use. They are dose related and predictable.</p>
                        
                        <h3>Poisoning</h3>
                        <p>Poison is a 'substance which endangers life by severely affecting one or more vital functions'. General management includes:</p>

                        <ol class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">1</span>
                                <span class="list-content"><strong>Resuscitation and maintenance of vital functions:</strong> Patent airway, artificial respiration, maintenance of BP/heart beat, prevention of seizures, maintenance of body temperature and blood sugar.</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">2</span>
                                <span class="list-content"><strong>Termination of exposure (decontamination):</strong> Fresh air, washing skin/eyes. Induction of emesis or gastric lavage is useful only if performed within 2 hours of ingestion and is contraindicated in comatose patients or corrosive poisoning.</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">3</span>
                                <span class="list-content"><strong>Prevention of absorption:</strong> Activated charcoal ($1\text{ g/kg}$) adsorbs many chemicals. Ineffective for strong acids/alkalies, metallic salts, iodine, cyanide, alcohol.</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">4</span>
                                <span class="list-content"><strong>Hastening elimination:</strong> Alkalinization of urine (for acidic drugs like barbiturates, aspirin). Haemodialysis is effective for phenobarbitone, lithium, salicylate, etc.</span>
                            </li>
                        </ol>
                    </div>
                </section>

                <!-- Section 5: Drug Allergy -->
                <section class="content-section" id="drug-allergy">
                    <div class="section-header">
                        <div class="section-number">05</div>
                        <h2 class="section-title">
                            <span class="title-icon">ü§ß</span>
                            Drug Allergy (Hypersensitivity)
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Immunologically mediated reaction producing stereotype symptoms unrelated to the pharmacodynamic profile. Requires prior sensitization. Occurs in a small proportion of population.</p>

                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Type</th>
                                        <th>Mechanism</th>
                                        <th>Manifestations</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Type I (Anaphylactic)</strong></td>
                                        <td>IgE mediated. Release of histamine, leukotrienes.</td>
                                        <td>Urticaria, itching, angioedema, bronchospasm, anaphylactic shock. Immediate.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Type II (Cytolytic)</strong></td>
                                        <td>IgG/IgM mediated. Drug + tissue component act as antigen.</td>
                                        <td>Thrombocytopenia, agranulocytosis, haemolysis, organ damage.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Type III (Retarded/Arthus)</strong></td>
                                        <td>Circulating antibodies (IgG). AG:AB complexes precipitate in tissues.</td>
                                        <td>Serum sickness (fever, arthralgia), Stevens-Johnson syndrome. Develops in 3-4 days.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Type IV (Delayed)</strong></td>
                                        <td>Cell mediated (T-lymphocytes).</td>
                                        <td>Contact dermatitis, rashes, fever. Takes 2-3 days to develop.</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Treatment of Drug Allergy</h3>
                        <ul>
                            <li><strong>Immediate cessation</strong> of the drug.</li>
                            <li><strong>Antihistamines ($H_1$):</strong> For mild reactions (itching, urticaria).</li>
                            <li><strong>Adrenaline (0.5 mg i.m.):</strong> The only life saving measure in anaphylactic shock and laryngeal angioedema.</li>
                            <li><strong>Glucocorticoids (i.v.):</strong> For severe/prolonged reactions. Effective in Type II, III and IV reactions.</li>
                        </ul>

                        <hr>

                        <h3>Photosensitivity</h3>
                        <div class="grid grid-2">
                            <div class="grid-item">
                                <h4>Phototoxic</h4>
                                <p>Drug accumulates in skin, absorbs light, causes local tissue damage (sunburn-like). Dose related. <br><em>Drugs:</em> Tetracyclines, nalidixic acid.</p>
                            </div>
                            <div class="grid-item">
                                <h4>Photoallergic</h4>
                                <p>Cell mediated immune response. Papular/eczematous contact dermatitis. Non-dose related.<br><em>Drugs:</em> Sulfonamides, chloroquine.</p>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 6: Dependence -->
                <section class="content-section" id="dependence">
                    <div class="section-header">
                        <div class="section-number">06</div>
                        <h2 class="section-title">
                            <span class="title-icon">üíä</span>
                            Dependence & Addiction
                        </h2>
                    </div>

                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker"></span>
                                <span class="list-content"><strong>Drug Dependence:</strong> Altered physiological state produced by repeated administration necessitating continued presence of drug to maintain equilibrium. Withdrawal results in abstinence syndrome. (Physical dependence). <em>Drugs:</em> Opioids, barbiturates, alcohol.</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker"></span>
                                <span class="list-content"><strong>Drug Addiction:</strong> Pattern of compulsive drug use characterized by overwhelming involvement with the use of a drug. Procuring and using the drug takes precedence over other activities. (Psychological dependence).</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker"></span>
                                <span class="list-content"><strong>Drug Abuse:</strong> Use of a drug by self medication in a manner and amount that deviates from approved medical and social patterns.</span>
                            </li>
                        </ul>

                        <div class="callout callout--note">
                            <div class="callout-header">
                                <span class="callout-icon">‚ö°</span>
                                <h4 class="callout-title">Drug Withdrawal Reactions</h4>
                            </div>
                            <div class="callout-content">
                                <p>Sudden interruption of therapy with certain drugs results in worsening of the clinical condition (rebound).</p>
                                <ul>
                                    <li><strong>Corticosteroids:</strong> Acute adrenal insufficiency.</li>
                                    <li><strong>Clonidine:</strong> Severe hypertension, restlessness.</li>
                                    <li><strong>$\beta$-blockers:</strong> Worsening of angina, MI.</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 7: Teratogenicity -->
                <section class="content-section" id="teratogenicity">
                    <div class="section-header">
                        <div class="section-number">07</div>
                        <h2 class="section-title">
                            <span class="title-icon">ü§∞</span>
                            Teratogenicity & Other Effects
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Capacity of a drug to cause foetal abnormalities. The thalidomide disaster (phocomelia) highlighted this. Drugs can affect the foetus at 3 stages: fertilization/implantation, organogenesis (18-55 days - most vulnerable), and growth/development.</p>

                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Drug</th>
                                        <th>Abnormality</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Thalidomide</td>
                                        <td>Phocomelia, multiple defects</td>
                                    </tr>
                                    <tr>
                                        <td>Anticancer drugs (methotrexate)</td>
                                        <td>Cleft palate, hydrocephalus, foetal death</td>
                                    </tr>
                                    <tr>
                                        <td>Androgens/Progestins</td>
                                        <td>Virilization of female foetus</td>
                                    </tr>
                                    <tr>
                                        <td>Tetracyclines</td>
                                        <td>Discoloured/deformed teeth, retarded bone growth</td>
                                    </tr>
                                    <tr>
                                        <td>Warfarin</td>
                                        <td>Depressed nose, eye/hand defects</td>
                                    </tr>
                                    <tr>
                                        <td>Phenytoin</td>
                                        <td>Cleft lip/palate, microcephaly</td>
                                    </tr>
                                    <tr>
                                        <td>ACE inhibitors</td>
                                        <td>Hypoplasia of organs, growth retardation</td>
                                    </tr>
                                    <tr>
                                        <td>Isotretinoin</td>
                                        <td>Craniofacial, heart and CNS defects</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Mutagenicity and Carcinogenicity</h3>
                        <p>Capacity to cause genetic defects and cancer respectively. Usually due to covalent interaction with DNA. <em>Drugs:</em> Anticancer drugs, radioisotopes, estrogens.</p>

                        <h3>Drug induced diseases (Iatrogenic)</h3>
                        <p>Functional disturbances caused by drugs which persist even after withdrawal.</p>
                        <ul>
                            <li>Peptic ulcer by NSAIDs.</li>
                            <li>Parkinsonism by phenothiazines.</li>
                            <li>Hepatitis by isoniazid.</li>
                        </ul>
                    </div>
                </section>

                <!-- Problem Directed Study -->
                <section class="content-section" id="problem-study">
                    <div class="section-header">
                        <div class="section-number">08</div>
                        <h2 class="section-title">
                            <span class="title-icon">üß©</span>
                            Problem Directed Study
                        </h2>
                    </div>

                    <div class="content-card">
                        <div class="callout callout--warning">
                            <div class="callout-header">
                                <span class="callout-icon">‚ùì</span>
                                <h4 class="callout-title">Case Study 6.1</h4>
                            </div>
                            <div class="callout-content">
                                <p>A 40-year-man weighing 60 kg suffering from chronic cough with expectoration and fever was diagnosed to have cavitary pulmonary tuberculosis. He was put on the standard 1st line antitubercular regimen consisting of isoniazid (H) + rifampin (R) + pyrazinamide (Z) + ethambutol (E). His condition improved, but in the 4th week he developed jaundice with enlarged tender liver and rise in serum bilirubin as well as serum transaminase levels. He was suspected to have developed antitubercular drug induced hepatitis.</p>
                                <p><strong>(a) Should his antitubercular treatment be stopped or continued?</strong><br>
                                <strong>(b) How would you proceed to confirm and identify the causative drug, and then select the alternative regimen?</strong></p>
                                <p><em>(See Appendix-1 for solution)</em></p>
                            </div>
                        </div>
                    </div>
                </section>

            </main>

            <nav class="document-nav">
                <div class="nav-container">
                    <a href="topic-05-pharmacotherapy.html" class="nav-button nav-button--large nav-button--previous">
                        <div class="nav-label">Previous</div>
                        <div class="nav-title">Pharmacotherapy</div>
                    </a>
                    
                    <div class="document-progress">
                        <div class="progress-indicator">
                            <span>6</span>
                            <span class="progress-separator">/</span>
                            <span>13</span>
                        </div>
                        <div class="progress-bar-container">
                            <div class="progress-bar-fill" style="width: 46.1%;"></div>
                        </div>
                        <div class="progress-label">Topic Progress</div>
                    </div>
                    
                    <a href="topic-07-ans-general.html" class="nav-button nav-button--large nav-button--next">
                        <div class="nav-label">Next</div>
                        <div class="nav-title">ANS: General Considerations</div>
                    </a>
                </div>
            </nav>
        </article>
    </div>
</div>

<script src="../js/theme.js"></script>
<script src="../js/navigation.js"></script>
<script src="../js/interactions.js"></script>
</body>
</html>
